genprowebdirectory
News
Insights
Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Genetically Modified Pigs May Prevent Bacon Shortages
News
Human Sex Reversal Attributed to Gain or Loss of Regulatory DNA
News
Mission Bio Raises $30M, Plans for Expansion into Gene Editing, Further…
News
CRISPR without the Chop Reverses Genetic Obesity in Mice
GWAS
Genomic Model Developed to Better Understand Neuropsychiatric Disorders
Insights
Insights
The Netherlands Ups Its Biopharma Game
Commentary
The Untold CRISPR Story
Insights
Top 10 Molecular Millionaires of 2018
Insights
A Step Forward for Pediatric Precision Oncology
Insights
Human Genome Editing Committee Urges Halt in Germline Editing Trials
Lists
Insights
Top 10 Molecular Millionaires of 2018
Lists
Top 10 Pharma Companies of 2018
Lists
Top 25 Biotech Companies of 2018
Lists
Top 10 Asia Biopharma Clusters 2018
Lists
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Genetically Modified Pigs May Prevent Bacon Shortages
News
Human Sex Reversal Attributed to Gain or Loss of Regulatory DNA
News
Mission Bio Raises $30M, Plans for Expansion into Gene Editing, Further…
News
CRISPR without the Chop Reverses Genetic Obesity in Mice
Magazine
December 2018 Vol. 38 No. 21
Full-Stack Genome Engineering Can Simplify CRISPR Workflows
December 2018 Vol. 38 No. 21
Layer by Layer: 3D Bioprinting on the Rise
December 2018 Vol. 38 No. 21
MicroRNA Profilers Cite Reconcilable Differences
December 2018 Vol. 38 No. 21
Single-Use Puzzles Come with Many Pieces
December 2018 Vol. 38 No. 21
Using Big Data to Treat the Whole Patient
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
GENcast
GENcast: Cancer Diagnostics and PD-L1
eBooks
Cell Therapy Today…New Developments in Immunotherapy
Videos
Zika: The Enemy of My Enemy
December 2018 Vol. 38 No. 21
Compact Refrigerators
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
T Cells
CAR T-Cells
CAR T-Cells
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CAR T-Cells
Cell Therapy Manufacturing: The Supply Chain Challenge
CAR T-Cells
Identification of Sprouty 1 and Sprouty 2 Provide Basis for New Immunotherapies
CAR T-Cells
Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies
CAR T-Cells
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
CAR T-Cells
Amgen, MD Anderson Launch Two Cancer Collaborations
CAR T-Cells
Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and...
CAR T-Cells
MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company
CAR T-Cells
FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501
CAR T-Cells
Celgene to Acquire Juno for $9B, Expanding CAR-T, TCR Presence
CAR T-Cells
Kite, Pfizer to Assess Yescarta-Utomilumab Combination in Lymphoma
CAR T-Cells
Novel Biomaterials Boost T-Cell Production
CAR T-Cells
Cancer Immunotherapy Channeled via Remote Control
CAR T-Cells
3D Bioscaffold Mimics Antigen-Presenting Cells for Improved T-Cell Expansion
CAR T-Cells
CAR-Engineered Blood Stem Cells Offer New Hope for Long-Term HIV Gene...
CAR T-Cells
VEGF-A Found Critical in Helping T Cells to Kill Tumors
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![SUPRA CAR-T offers several advantages over existing CAR-T therapy. [Cell]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr27_2018_Cell_ImprovingCarTTherapy2114263165-324x160.jpg "Controllable “Swiss Army Knife” CAR T Cells Solve Key Efficacy and Safety Issues")
![Regeneron Pharmaceuticals demonstrated its VelocImmune technology in a study published in 2015 in Proceedings of the National Academy of Sciences showing the rapid generation of fully human neutralizing antibodies against Middle East Respiratory Syndrome coronavirus (MERS-CoV) and development of a humanized mouse model for MERS-CoV infection (pictured). Regeneron will use VelocImmune and other VelociSuite platform technologies in a collaboration with bluebird bio to develop new immune cell therapies for cancer. [Source: PNAS]](https://www.genengnews.com/wp-content/uploads/2018/08/F7large2321726613-265x198.jpg "Regeneron to Invest $100M in bluebird bio as Companies Partner in Cancer Therapies")
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-265x198.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")